First Trust Advisors LP Insmed Inc Transaction History

First Trust Advisors LP

$108 Billion
Q1 2025

A detailed history of First Trust Advisors LP transactions in Insmed Inc stock. As of the latest transaction made, First Trust Advisors LP holds 26,216 shares of INSM stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,216

Previous 66,690 60.69%

Holding current value

$2.69 Million

Previous $4.6 Million 56.56%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$65.25 - $83.83 $2.64 Million - $3.39 Million	-40,474 Reduced 60.69%	26,216 $2 Million
Q4 2024 Feb 13, 2025	SELL	$66.29 - $76.63 $14.2 Million - $16.4 Million	-214,129 Reduced 76.25%	66,690 $4.6 Million
Q3 2024 Nov 13, 2024	BUY	$62.0 - $79.01 $14 Million - $17.8 Million	225,371 Added 406.45%	280,819 $20.5 Million
Q2 2024 Aug 13, 2024	SELL	$22.0 - $69.71 $30.4 Million - $96.3 Million	-1,381,726 Reduced 96.14%	55,448 $3.72 Million
Q1 2024 May 13, 2024	BUY	$25.72 - $29.94 $34.5 Million - $40.2 Million	1,341,242 Added 1398.12%	1,437,174 $39 Million
Q4 2023 Feb 13, 2024	BUY	$23.42 - $31.74 $303,078 - $410,747	12,941 Added 15.59%	95,932 $2.97 Million
Q3 2023 Nov 13, 2023	BUY	$19.86 - $26.93 $1.65 Million - $2.23 Million	82,991 New	82,991 $2.1 Million
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $1.06 Million - $1.42 Million	-65,122 Reduced 62.26%	39,481 $673,000
Q4 2022 Feb 09, 2023	BUY	$16.98 - $23.15 $1.53 Million - $2.09 Million	90,386 Added 635.76%	104,603 $2.09 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $4,739 - $6,403	-227 Reduced 1.57%	14,217 $306,000
Q2 2022 Aug 12, 2022	SELL	$17.07 - $25.71 $5,564 - $8,381	-326 Reduced 2.21%	14,444 $285,000
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $301,603 - $415,480	14,770 New	14,770 $347,000
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $451,154 - $591,963	-20,087 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $1.02 Million - $1.52 Million	-42,164 Reduced 67.73%	20,087 $572,000
Q1 2021 May 14, 2021	SELL	$32.28 - $44.3 $3.42 Million - $4.7 Million	-106,099 Reduced 63.02%	62,251 $2.12 Million
Q4 2020 Feb 02, 2021	BUY	$31.45 - $40.54 $2.67 Million - $3.45 Million	85,055 Added 102.11%	168,350 $5.6 Million
Q3 2020 Nov 05, 2020	BUY	$26.0 - $34.5 $1.01 Million - $1.33 Million	38,663 Added 86.63%	83,295 $2.68 Million
Q2 2020 Jul 22, 2020	BUY	$14.11 - $29.42 $629,757 - $1.31 Million	44,632 New	44,632 $1.23 Million

Others Institutions Holding INSM

# of Institutions

489

Shares Held

197M

Call Options Held

892K

Put Options Held

1.77M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $13.9B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Insmed Inc Transaction History